Search Results - Naser, Eyad

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival by Oubari, Sara (Author) , Papathanasiou, Maria (Author) , Michel, Lars (Author) , Rassaf, Tienush (Author) , Thimm, Andreas (Author) , Hagenacker, Tim (Author) , Ehling, Daniela (Author) , Wieczorek, Stefan (Author) , Naser, Eyad (Author) , Hegenbart, Ute (Author) , Schönland, Stefan (Author) , Dührsen, Ulrich (Author) , Reinhardt, Hans Christian (Author) , Carpinteiro, Alexander (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival by Oubari, Sara (Author) , Hegenbart, Ute (Author) , Schoder, Renate (Author) , Steinhardt, Maximilian (Author) , Papathanasiou, Maria (Author) , Rassaf, Tienush (Author) , Thimm, Andreas (Author) , Hagenacker, Tim (Author) , Naser, Eyad (Author) , Duhrsen, Ulrich (Author) , Reinhardt, Hans C. (Author) , Kortum, Martin (Author) , Agis, Hermine (Author) , Schönland, Stefan (Author) , Carpinteiro, Alexander (Author) ,


    Get full text
    Article (Journal) Online Resource